Island Pharmaceuticals Ltd
ASX:ILA
Island Pharmaceuticals Ltd
ASX:ILA
Price:
0.365
AUD
4.29%
Market Cap:
AU$107.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Island Pharmaceuticals Ltd
ASX:ILA
|
AU |
|
Bharat Electronics Ltd
NSE:BEL
|
IN |
|
G
|
Gigastorage Corp
TWSE:2406
|
TW |
|
Hempacco Co Inc
NASDAQ:HPCO
|
US |
|
J
|
JES International Holdings Ltd
SGX:EG0
|
CN |
|
I
|
Imagis Co Ltd
KOSDAQ:115610
|
KR |
Income Statement
Earnings Waterfall
Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd
Income Statement
Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd
Currency: AUD
| Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
+141%
|
0
-7%
|
0
-54%
|
0
-72%
|
0
+4 423%
|
0
+185%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(3)
|
(4)
|
(3)
|
(2)
|
(3)
|
(3)
|
(4)
|
(7)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(5)
|
|
| Research & Development |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Operating Income |
(3)
N/A
|
(4)
-25%
|
(3)
+17%
|
(2)
+16%
|
(3)
-18%
|
(3)
-12%
|
(4)
-22%
|
(7)
-85%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(3)
N/A
|
(3)
-29%
|
(3)
+16%
|
(2)
+16%
|
(3)
-21%
|
(3)
-13%
|
(4)
-21%
|
(7)
-84%
|
|
| Net Income | |||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(4)
|
(7)
|
|
| Net Income (Common) |
(3)
N/A
|
(3)
-29%
|
(3)
+16%
|
(2)
+16%
|
(3)
-21%
|
(3)
-13%
|
(4)
-21%
|
(7)
-84%
|
|
| EPS (Diluted) |
-0.03
N/A
|
-0.04
-33%
|
-0.03
+25%
|
-0.03
N/A
|
-0.03
N/A
|
-0.03
N/A
|
-0.02
+33%
|
-0.03
-50%
|
|
Switch to:
Switch to:
See Also
Discover More
